Hemoglobin Variability and Mortality in ESRD
Open Access
- 1 December 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 18 (12), 3164-3170
- https://doi.org/10.1681/asn.2007010058
Abstract
Hemoglobin levels vary substantially over time in hemodialysis patients, and this variability may portend poor outcomes. For a given patient, hemoglobin concentration over time can be described by absolute levels, rate of change, or by the difference between observed level and expected level based on the preceding trend (i.e., seemingly random variability). We investigated the independent associations of these different methods of describing hemoglobin over time with mortality in a retrospective cohort of 34,963 hemodialysis patients. Hemoglobin concentration over time was modeled with linear regression for each subject, and the model was then used to define the subject's absolute level of hemoglobin (intercept), temporal trend in hemoglobin (slope), and hemoglobin variability (residual standard deviation). Survival analyses indicated that each 1g/dl increase in the residual standard deviation was associated with a 33% increase in rate of death, even after adjusting for multiple covariates. Patient characteristics accounted for very little of the variation in our hemoglobin variability metric (R2 = 0.019). We conclude that greater hemoglobin variability is independently associated with higher mortality.Keywords
This publication has 26 references indexed in Scilit:
- Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving HemodialysisJama-Journal Of The American Medical Association, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and AnemiaNew England Journal of Medicine, 2006
- Hemoglobin Level VariabilityClinical Journal of the American Society of Nephrology, 2006
- Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis PatientsJournal of the American Society of Nephrology, 2006
- Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinKidney International, 2005
- History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment RegimensThe International Journal of Biostatistics, 2005
- Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patientsKidney International, 2004
- Hemoglobin variability in epoetin-treated hemodialysis patientsKidney International, 2003
- G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS PatientsEpidemiology, 1992